Stephen Eeden to Retrospective Studies
This is a "connection" page, showing publications Stephen Eeden has written about Retrospective Studies.
Connection Strength
0.796
-
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054.
Score: 0.055
-
Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
Score: 0.054
-
Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010 Jan; 33(1):55-60.
Score: 0.051
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.046
-
High-resolution mapping of traffic related air pollution with Google street view cars and incidence of cardiovascular events within neighborhoods in Oakland, CA. Environ Health. 2018 05 15; 17(1):38.
Score: 0.046
-
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
Score: 0.045
-
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
Score: 0.044
-
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 06; 197(6):1448-1454.
Score: 0.042
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.042
-
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.
Score: 0.040
-
Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management. J Urol. 2016 Sep; 196(3):734-40.
Score: 0.040
-
Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California. Sleep. 2015 Jul 01; 38(7):1009-15.
Score: 0.038
-
Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer. J Urol. 2015 Jun; 193(6):1956-62.
Score: 0.036
-
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014 May 01; 32(13):1324-30.
Score: 0.035
-
Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
Score: 0.034
-
Parturition events and risk of urinary incontinence in later life. Neurourol Urodyn. 2011 Nov; 30(8):1456-61.
Score: 0.029
-
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
Score: 0.026
-
Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology. 2007 Aug 14; 69(7):676-80.
Score: 0.022
-
Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005 May; 105(5 Pt 1):1052-7.
Score: 0.019
-
Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer. 2002 Dec 01; 95(11):2308-15.
Score: 0.016
-
Different slopes for different folks: socioeconomic and racial/ethnic disparities in asthma and hay fever among 173,859 U.S. men and women. Environ Health Perspect. 2002 Apr; 110 Suppl 2:211-6.
Score: 0.015
-
The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000 Mar; 57(1):92-109.
Score: 0.013
-
Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology. 1992 May; 3(3):253-7.
Score: 0.008